Funder
JDRF
The University of Toledo, College of Medicine and Life Sciences grants (JCJ).
Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. Gorus, F. K., Keymeulen, B., Veld, P. A. I. & Pipeleers, D. G. Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase. Expert Rev. Clin. Immunol. 9, 1173–1183 (2013).
2. Jäger, A., Kuchroo, V. K., Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation. Scand. J. Immunol. 72, 173–184
3. Ferraro, A. et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60, 2903–2913 (2011).
4. Bulek, A. M. et al. Structural basis for the killing of human beta cells by CD8 + T cells in type 1 diabetes. Nat. Immunol. (2012).
5. Skowera, A. et al. CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest. 118, 3390–3402 (2008).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献